Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile

Vaccine administration is one of the most efficient ways to control the current coronavirus disease 2019 (COVID-19) pandemic. However, the appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants can avoid the immunity generated by vaccines. Thus, in patients with a comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrera-Avalos, Carlos, Luraschi, Roberto, Acuña-Castillo, Claudio, Vidal, Mabel, Mella-Torres, Andrea, Inostroza-Molina, Ailen, Vera, Rodrigo, Vargas, Sergio, Hernández, Iván, Perez, Christian, Vallejos-Vidal, Eva, Valdés, Daniel, Imarai, Mónica, Reyes-López, Felipe E., Sandino, Ana María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977486/
https://www.ncbi.nlm.nih.gov/pubmed/35387187
http://dx.doi.org/10.3389/fpubh.2022.797569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977486/
https://www.ncbi.nlm.nih.gov/pubmed/35387187
http://dx.doi.org/10.3389/fpubh.2022.797569

Ejemplares similares